Literature DB >> 16259577

Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications.

Aki Sakurai1, Ai Tamura, Yuko Onishi, Toshihisa Ishikawa.   

Abstract

Pharmacogenomics, the study of the influence of genetic factors on drug action, is increasingly important for predicting pharmacokinetics profiles and/or adverse reactions to drugs. Drug transporters, as well as drug metabolism play pivotal roles in determining the pharmacokinetic profiles of drugs and their overall pharmacological effects. There is an increasing number of reports addressing genetic polymorphisms of drug transporters. However, information regarding the functional impact of genetic polymorphisms in drug transporter genes is still limited. Detailed functional analysis in vitro may provide clear insight into the biochemical and therapeutic significance of genetic polymorphisms. This review addresses functional aspects of the genetic polymorphisms of human ATP-binding cassette transporters, ABCB1 and ABCG2, which are critically involved in the pharmacokinetics of drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259577     DOI: 10.1517/14656566.6.14.2455

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  12 in total

1.  Deferasirox-induced serious adverse reaction in a pediatric patient: pharmacokinetic and pharmacogenetic analysis.

Authors:  M Marano; G Bottaro; B Goffredo; F Stoppa; M Pisani; A M Marinaro; F Deodato; C Dionisi-Vici; E Clementi; F S Falvella
Journal:  Eur J Clin Pharmacol       Date:  2015-09-24       Impact factor: 2.953

2.  The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.

Authors:  C Rafaniello; M Sessa; F F Bernardi; M Pozzi; S Cheli; D Cattaneo; S Baldelli; M Molteni; R Bernardini; F Rossi; E Clementi; C Bravaccio; S Radice; A Capuano
Journal:  Pharmacogenomics J       Date:  2017-07-18       Impact factor: 3.550

3.  Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.

Authors:  C A Fernandez; C Smith; W Yang; R Lorier; K R Crews; N Kornegay; J K Hicks; C F Stewart; J D Kawedia; L B Ramsey; C Liu; W E Evans; M V Relling; U Broeckel
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

Review 4.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

5.  Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics.

Authors:  Cristina Gervasoni; Dario Cattaneo; Felicia Stefania Falvella; Paola Vitiello; Stefania Cheli; Laura Milazzo; Emilio Clementi; Agostino Riva
Journal:  Eur J Clin Pharmacol       Date:  2013-04-25       Impact factor: 2.953

6.  Joining the dots: Answers.

Authors:  Niladri Bose; Kaustabh Chaudhuri; Mordi Muorah; Rajiv Sinha
Journal:  Pediatr Nephrol       Date:  2022-01-27       Impact factor: 3.714

7.  Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.

Authors:  S S Jhee; M Yen; L Ereshefsky; M Leibowitz; M Schulte; B Kaeser; L Boak; A Patel; G Hoffmann; E P Prinssen; C R Rayner
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

Review 8.  Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Authors:  Stephen Toovey; Craig Rayner; Eric Prinssen; Tom Chu; Barbara Donner; Bharat Thakrar; Regina Dutkowski; Gerhard Hoffmann; Alexander Breidenbach; Lothar Lindemann; Ellen Carey; Lauren Boak; Ronald Gieschke; Susan Sacks; Jonathan Solsky; Ian Small; David Reddy
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing.

Authors:  Casey R Dorr; Baolin Wu; Rory P Remmel; Amutha Muthusamy; David P Schladt; Juan E Abrahante; Weihua Guan; Roslyn B Mannon; Arthur J Matas; William S Oetting; Pamala A Jacobson; Ajay K Israni
Journal:  Pharmacogenomics J       Date:  2018-11-16       Impact factor: 3.550

10.  Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4.

Authors:  Megumi Tsukamoto; Shiori Sato; Kazuhiro Satake; Mizuki Miyake; Hiroshi Nakagawa
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.